Genomics is transforming modern infectious disease testing and surveillance, and expanding our understanding of pathogen evolution, and antibiotic resistance. In turn, public health professionals are changing the methods they use to research, monitor, and prevent epidemics and pandemics of high-profile infectious diseases such as influenza, tuberculosis, Ebola, and more recently, coronavirus.
In this webcast, the speaker will review the broad applicability of NGS for responding to the SARS-CoV-2 pandemic, from initial detection and characterization of the novel coronavirus to monitoring, surveillance and diagnostic detection. Illumina NGS provides workflow and analysis solutions across the clinical and public health continuum.
Infectious Disease Specalist